Choose New Jersey, a nonprofit economic development organization, announced that Enzene Biosciences, Ltd., a global biotech company based in Pune, India, will open its state-of-the-art biopharmaceutical manufacturing plant on the Princeton West Innovation Campus in Hopewell. Operations in the new facility, the company’s first location outside of India, are expected to begin in June 2024.
 
As a Contract Development and Manufacturing Organization (CDMO), Enzene Biosciences, a subsidiary of Alkem Laboratories, Ltd., provides services to global pharmaceutical companies, partnering with them in their drug development and manufacturing processes. As part of Enzene’s expansion plans, the company will initially hire 50 employees and grow to 300 employees at the NJ facility. 
 
“We are so proud to welcome Enzene to New Jersey’s thriving life sciences ecosystem,” said Wesley Mathews, President and CEO of Choose New Jersey. “Yet another Indian biopharma company has established itself in the state, demonstrating the strength of the New Jersey-India economic partnership. Beyond economic and commercial ties, our academic and cultural connections make it the perfect fit for Indian companies looking to expand to North America. Enzene’s growth in this sector highlights New Jersey’s global presence throughout all areas of the biopharmaceutical industry — from clinical trials to large-scale manufacturing.”
 
“Enzene Biosciences is thrilled to establish our manufacturing operations in New Jersey, as it allows us to extend our local manufacturing capabilities to our valued North American clients,” said Dr. Himanshu Gadgil, CEO of Enzene Biosciences. “We are excited to provide them with access to our cutting-edge continuous manufacturing platform, which enables streamlined and efficient production processes. New Jersey’s highly skilled workforce, state-of-the-art infrastructure, and renowned academic institutions make it an ideal location for Enzene, ensuring that we can deliver exceptional services and support to our clients in the U.S.”